Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Lunglife Ai Inc | LLAI | London | Ordinary Share |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| 0.25 | 2.86% | 9.00 | 14:27:35 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 8.75 | 8.75 | 9.50 | 9.00 | 8.75 |
| Industry Sector |
|---|
| PHARMACEUTICALS & BIOTECHNOLOGY |
| Top Posts |
|---|
Posted at 23/8/2024 01:58 by ohisay Investor Meet ..Lets see if they can capitalise on this development in the next six months , MolDX, which oversees the evaluation of molecular diagnostics for Medicare, was considering additional evidence that could broaden the scope of coverage, presenting further opportunities for LungLife. With the LCD in place, LungLife said it had successfully secured the three key components necessary for the commercial launch of LungLB - a billing code, a set price, and now Medicare coverage. That, it said, paved the way for wider adoption of the test by healthcare providers, facilitating earlier and more accurate lung cancer diagnoses for patients with indeterminate lung nodules. “Having a local coverage determination (LCD) for risk stratification testing of indeterminate lung nodules represents a key opportunity for our company,” said chief executive officer Paul Pagano. “It enables us to progress to the next stage of commercialisation by providing a clear pathway to make our innovative LungLB test more accessible and reimbursable under Medicare. “This supports our commitment to enabling 80% of lung cancer to be detected early.” |
Posted at 06/4/2024 01:39 by ohisay Investor Meet recording .Quite an impressive Road map for commercialisation in the next 12 months ..worth keeping an eye on . |
Posted at 19/7/2021 13:05 by gocanes Investor presentation this Thursday @ 10am - Matthew Walls, CEO and Paul Foulger, CFO will provide a live investor presentation via the Investor Meet Company platform at 10am BST on Thursday, 22 July 2021. The presentation is open to all existing and potential shareholders. Questions can be submitted pre-event via your Investor Meet Company dashboard up until 9am the day before the meeting or at any time during the live presentation. Investors can sign up to Investor Meet Company for free and add to meet GENinCode plc via:hxxps://www.inve |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
